Peptide cross-reactivity: The original sin of vaccines

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 4, 2012, Pages 1393-1401

  Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmune diseases; Microbial immunoevasion; Microbial vs human peptide commonality; Peptide cross reactivity; Review; Safe vaccines; Sequence uniqueness

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ANTIBODY; ANTIGEN; CALCIUM PHOSPHATE; HEAVY METAL; MONOCLONAL ANTIBODY; PEPTIDE; VACCINE;

ADJUVANT CHEMOTHERAPY; AMINO ACID SEQUENCE; ARTICLE; CROSS REACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOSURVEILLANCE; MICROBIAL IMMUNITY; MOLECULAR MIMICRY; NONHUMAN; IMMUNOLOGY; REVIEW;

CROSS REACTIONS; HUMANS; MOLECULAR MIMICRY; PEPTIDES; VACCINES;

EID: 84863999676     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s341     Document Type: Article

References (97)

1. Coutinho A: Beyond clonal selection and network. Immunol Rev 110, 63-87 (1989) (Pubitemid 19216009)
2. M Fichman, JE Keelan: Resister's logic: the antivaccination arguments of Alfred Russel Wallace and their role in the debates over compulsory vaccination in England, 1870-1907. Stud Hist Philos Biol Biomed Sci 38, 585-607 (2007)
3. MM Davis: A prescription for human immunology. Immunity 29, 835-838 (2008)
4. RN Germain: Vaccines and the future of human immunology. Immunity 33, 441-450 (2010)
5. H Eagle, RB Hogan: On the presence in syphilitic serum of antibodies to spirochetes, their relation to so called Wassermann reagin, and their significance for the serodiagnosis of syphilis. J Exp Med 71, 215-230 (1940)
6. S Schlaff, SW Rosen, J Roth: Antibody to human folliclestimulating hormone: cross-reactivity with three other hormones. J Clin Invest 47, 1722-1729 (1968)
7. W Sadee, AM Finn, P Schmiedek, A Baethmann: Aldosterone plasma radioimmunoassay interference by a spirolactone metabolite. Steroids 25, 301-311 (1975)
8. SL Keasey, KE Schmid, MS Lee, J Meegan, P Tomas, M Minto, AP Tikhonov, B Schweitzer, RG Ulrich: Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol Cell Proteomics 8, 924-935 (2009)
9. WB Elliott, JP Holbrook, R Penniall: Studies on a cytochrome oxidase antibody. III. Cross reactivity. Biochim Biophys Acta 251, 277-280 (1971)
10. Y Yamauchi, A Litwin, L Adams, H Zimmer, EV Hess: Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates. J Clin Invest 56, 958-969 (1975)
11. S Kawakita, H Iwamoto: Studies on the pathogenesis of rheumatic heart disease. An immunological relationship between the polysaccharide of group A streptococcus and the glycoprotein of heart valve. Jpn Circ J 39, 439-446 (1975)
12. G Kohler, C Milstein: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497 (1975)
13. R Dulbecco, M Unger, M Bologna, H Battifora, P Syka, S Okada: Cross-reactivity between Thy-1 and a component of intermediate filaments demonstrated using a monoclonal antibody. Nature 292, 772-774 (1981) (Pubitemid 11015337)
14. EM Lafer, J Rauch, C Andrzejewski Jr, D Mudd, B Furie, B Furie, RS Schwartz: Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153, 897-909 (1981) (Pubitemid 11104738)
15. E Muso, L Jacob: A polyspecific monoclonal anti-DNA autoantibody also binds to cell-surface protein(s). Clin Immunol Immunopathol 42, 370-374 (1987) (Pubitemid 17041915)
16. AJ Laster, DS Pisetsky, BF Haynes: Polyspecific reactivity of a murine monoclonal antibody that binds to nuclear matrix-Associated, chromatin-bound autoantigens. Clin Immunol Immunopathol 44, 187-205 (1987) (Pubitemid 17152541)
17. T Ternynck, S Avrameas: Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol Rev 94, 99-112 (1986) (Pubitemid 17210545)
18. C Garzelli, Basolo F, Puglisi C, Pacciardi A: Multiple organ-reactivity of monoclonal autoantibodies to mouse erythrocytes. Experientia 43, 912-914 (1987)
19. M Sutjita, A Hohmann, R Comacchio, J Bradley: Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids. Clin Exp Immunol 73, 191-197 (1988)
20. J Pons, JR Stratton, JF Kirsch: How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme? Protein Sci 11, 2308-2315 (2002)
21. E Sidorova: Human monoclonal antibodies to MN-24 peptide of gp 120 HIV-1. Hum Antibodies 9, 107-110 (1999) (Pubitemid 30099253)
22. BF Haynes, J Fleming, EW St Clair, H Katinger, G Stiegler, R Kunert, J Robinson, RM Scearce, K Plonk, HF Staats, TL Ortel, HX Liao, SM Alam: Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908 (2005) (Pubitemid 40941873)
23. L Otte, T Knaute, J Schneider-Mergener, A Kramer: Molecular basis for the binding polyspecificity of an anticholera toxin peptide 3 monoclonal antibody. J Mol Recognit 19, 49-59 (2006) (Pubitemid 43129786)
24. GD Carpenter: Mimicry, as viewed by Professor Shull. Science 85, 356-359 (1937)
25. RT Damian: Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Naturalist 98, 129-149 (1964)
26. JT Weinfurter, GE May, T Soma, AJ Hessell, Leon EJ, CE Macnair, SM Piaskowski, K Weisgrau, J Furlott, NJ Maness, J Reed, NA Wilson, EG Rakasz, DR Burton, TC Friedrich: Macaque long-Term nonprogressors resist superinfection with multiple CD8+ T cell escape variants of simian immunodeficiency virus. J Virol 85, 530-541 (2011)
27. S Yokota, T Okabayashi, N Fujii: The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection. Mediators Inflamm 184328 (2010)
28. M Ota, BH Duong, A Torkamani, CM Doyle, AL Gavin, T Ota, D Nemazee: Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol 185, 4128-4136 (2010)
29. IE Frohner, C Bourgeois, K Yatsyk, O Majer, K Kuchler: Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol Microbiol 71, 240-252 (2009)
30. JD Lambris, D Ricklin, BV Geisbrecht: Complement evasion by human pathogens. Nat Rev Microbiol 6, 132-142 (2008)
31. D Rowley, CR Jenkin: Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature 193, 151-154 (1962)
32. RF Shapiro, KB Wiesner, BL Bryan, PD Utsinger, D Resnick, JJ Castles: HLA-B27 and modified bone formation. Lancet 307, 230-231 (1976)
33. A Ebringer: Ankylosing spondylitis, immune-responsegenes and molecular mimicry. Lancet 313, 1186 (1979)
34. RS Fujinami, MB Oldstone, Z Wroblewska, ME Frankel, H Koprowski: Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA; 80, 2346-2350 (1983) (Pubitemid 13097186)
35. LJ Albert, RD Inman: Molecular mimicry and autoimmunity. N Engl J Med 341, 2068-2074 (1999) (Pubitemid 30035957)
36. C Benoist, D Mathis: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2, 797-801 (2001)
37. CW Ang, BC Jacobs, JD Laman: The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 25, 61-66 (2004) (Pubitemid 38167486)
38. JE Libbey, LL McCoy, RS Fujinami: Molecular mimicry in multiple sclerosis. Int Rev Neurobiol 79, 127-147 (2007)
39. S Acharya, S Shukla, SN Mahajan, SK Diwan: Molecular mimicry in human diseases: phenomena or epiphenomena? J Assoc Physicians India 58, 163-168 (2010)
40. A Kusalik, M Bickis, C Lewis, Y Li, G Lucchese, FM Marincola, D Kanduc: Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 28, 1260-1267 (2007) (Pubitemid 46843388)
41. D Kanduc, A Stufano, G Lucchese, A Kusalik: Massive peptide sharing between viral and human proteomes. Peptides 29, 1755-1766 (2008)
42. D Kanduc: Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol 8, 65-76 (2009)
43. D Kanduc: Penta-And hexapeptide sharing between HPV16 and Homo sapiens proteomes. Int J Med Med Sci 1, 387 (2009)
44. D Kanduc, A Lucchese, A Mittelman: Non-redundant peptidomes from DAPs: towards "the vaccine"? Autoimmun Rev 6, 290-294 (2007) (Pubitemid 46507994)
45. R Ricco, D Kanduc: Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 4, 75-81 (2010)
46. D Kanduc: Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics 4, 245-261 (2010)
47. G Lucchese, A Stufano, D Kanduc: Proposing lowsimilarity peptide vaccines against Mycobacterium tuberculosis. J Biomed Biotechnol 832341 (2010)
48. B Trost, A Kusalik, G Lucchese, G Kanduc: Bacterial peptides are intensively present throughout the human proteome. Self Nonself 1, 71-74 (2010)
49. B Trost, G Lucchese, A Stufano, M Bickis, A Kusalik, D Kanduc D: No human protein is exempt from bacterial motifs, not even one. Self Nonself 1, 328-334 (2010)
50. SL Bavaro, D Kanduc: Pentapeptide commonality between Corynebacterium diphtheriae toxin and the Homo sapiens proteome. Immunotherapy 3, 49-58 (2011)
51. SL Bavaro, M Calabro', D Kanduc: Pentapeptide sharing between Corynebacterium diphtheriae toxin and the human neural protein network. Immunopharmacol Immunotoxicol 33, 360-372 (2011)
52. D Kanduc: Immunogenicity in peptide-immunotherapy: from self/nonself to similar/dissimilar sequences. Adv Exp Med Biol 640, 198-207 (2008)
53. D Kanduc: HCV. Written in our DNA. Self Nonself 2, (2011) in press)
54. D Kanduc: The self/nonself issue: a confrontation between proteomes. Self Nonself 1, 255-258 (2010)
55. D Kanduc: Correlating low-similarity peptide sequences and allergenic epitopes. Curr Pharm Des 14, 289-295 (2008) (Pubitemid 351516873)
56. D Kanduc: Protein information content resides in rare peptide segments. Peptides 31, 983-988 (2010)
57. PG Schoofs, HM Geysen, DC Jackson, LE Brown, XL Tang, DO White: Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. J Immunol 140, 611-616 (1988)
58. S Tanabe: Epitope peptides and immunotherapy. Curr Protein Pept Sci 8, 109-118 (2007) (Pubitemid 46322273)
59. W Zeng, J Pagnon, DC Jackson: The C-Terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function. Mol Immunol 44: 3724-3731 (2007) (Pubitemid 46817668)
60. G Lucchese, A Stufano, B Trost, A Kusalik, D Kanduc: Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 33, 703-707 (2007) (Pubitemid 350165425)
61. JB Rothbard, ML Gefter: Interactions between immunogenic peptides and MHC proteins. Ann Rev Immunol 9, 527-565 (1991)
62. MJ Reddehase, JB Rothbard, UH Koszinowski: A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337, 651-653 (1989) (Pubitemid 19054293)
63. B Hemmer, T Kondo, B Gran, et al: Minimal peptide length requirements for CD4(+) T cell clones-implications for molecular mimicry and T cell survival. Int Immunol 12, 375-383 (2000) (Pubitemid 30142709)
64. R Tiwari, J Geliebter, A Lucchese, A Mittelman, D Kanduc: Computational peptide dissection of Melana/ MART-1 oncoprotein antigenicity. Peptides 25, 1865-1871 (2004) (Pubitemid 39389180)
65. EM Veys, P Hermanns, G Goldstein, P Kung, J Schindler, J Van Wauwe: Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. Int J Immunopharmacol 3, 313-319 (1981) (Pubitemid 11027818)
66. W Diezel, SR Waschke, K Forner: Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide. Biomed Biochim Acta 43, 9-12 (1984)
67. W Roszkowski, J Stachurska, B Gerdin, T Saldeen, M Kopec: Suppression of cell-mediated immune reactivity by peptides cleaved from human fibrinogen. Ups J Med Sci 90, 279-291 (1985) (Pubitemid 16180847)
68. IZ Siemion, E Nawrocka, J Slon, A Pedyczak, A Kubik, K Spiegel, M Zimecki, Z Wieczorek: Immunoregulatory activity of substance P fragments. Mol Immunol 27, 887-890 (1990) (Pubitemid 20293412)
69. Z Szewczuk, A Wilczynski, P Stefanowicz, W Fedorowicz, IZ Siemion, Z Wieczorek: Immunosuppressory mini-regions of HLA-DP and HLA-DR. Mol Immunol 36, 525-533 (1999) (Pubitemid 29386151)
70. P Stefanowicz, PJ Boratynski, A Staszewska, A Wilczynski, M Zimecki, Z Szewczuk: Threonine at position 6 is not essential for the immunosuppressive activity of HLADQ[ beta164-172]-hexapeptide. Mol Immunol 41, 911-917 (2004) (Pubitemid 38903175)
71. R Silva-Garcia, I Estrada-Garcia, R Ramos-Payan, A Torres-Salazar, ME Morales-Martinez, D Arenas-Aranda, JA Gimenez-Scherer, F Blanco-Favela, MG Rico-Rosillo: The effect of an anti-inflammatory pentapeptide produced by Entamoeba histolytica on gene expression in the U-937 monocytic cell line. Inflamm Res 57, 145-150 (2008)
72. DY Li, ZR Geng, HF Zhu, C Wang, DN Miao, PY Chen: Immunomodulatory activities of a new pentapeptide [Bursopentin] from the chicken bursa of Fabricius. Amino Acids 40, 505-515 (2011)
73. CA Janeway: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54, 1-13 (1989)
74. CK Fraser, KR Diener, MP Brown, JD Hayball: Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 6, 559-578 (2007) (Pubitemid 47281299)
75. A Wack, BC Baudner, AK Hilbert, I Manini, S Nuti, S Tavarini, H Scheffczik, M Ugozzoli, M Singh, J Kazzaz, E Montomoli, G Del Giudice, R Rappuoli, DT O'Hagan: Combination adjuvants for the induction of potent, longlasting antibody and T-cell responses to influenza vaccine in mice. Vaccine 26, 552-561 (2008)
76. E Tritto, F Mosca, E de Gregorio: Mechanism of action of licensed vaccine adjuvants. Vaccine 27, 3331-3334 (2009)
77. S Havarinasab, KM Pollard, P Hultman: Gold-And silver-induced murine autoimmunity requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol 155, 567-576 (2009)
78. CS Schmidt, WJ Morrow, NA Sheikh: Smart adjuvants. Expert Rev Vaccines 6, 391-400 (2007) (Pubitemid 46911602)
79. M Mizrahi, G Lalazar, A Ben Ya'acov, DM Livovsky, Y Horowitz, L Zolotarov, R Adler, D Shouval, Y Ilan: Betaglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination. Vaccine 26, 2589-2595 (2008)
80. T Yokochi, M Fukada, M Kawai, YH Zhang, GZ Jiang, K Takahashi: Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice. Infect Immun 60, 4953-4956 (1992)
81. S Williamson: Anti-vaccination leagues. Arch Dis Child 59, 1195-1196 (1984)
82. TP Weber: Alfred Russel Wallace and the antivaccination movement in Victorian England. Emerg Infect Dis 16, 664-668 (2010)
83. G Scarpelli: "Nothing in nature that is not useful". The anti-vaccination crusade and the idea of 'harmonia naturae' in Alfred Russel Wallace. Nuncius 7, 109-130 (1992)
84. A Beck: Issues in the anti-vaccination movement in England. Med Hist 4, 310-321 (1960)
85. D Kanduc: Peptimmunology: immunogenic peptides and sequence redundancy. Curr Drug Discov Technol 2, 239-244 (2005) (Pubitemid 43168115)
86. D Kanduc: Defining peptide sequences: from antigenicity to immunogenicity through redundancy. Curr Pharmacogenomics 4, 33-37 (2006)
87. D Kanduc: Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin Biol Ther 9, 45-53 (2009)
88. D Kanduc, L Tessitore, G Lucchese, A Kusalik, E Farber, FM Marincola: Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 57, 1215-1223 (2008)
89. L Polimeno, A Mittelman, L Gennero, A Ponzetto, G Lucchese, A Stufano, A Kusalik, D Kanduc: Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 34, 479-484 (2008) (Pubitemid 351569757)
90. A Lucchese, A Mittelman, L Tessitore, R Serpico, AA Sinha, D Kanduc: Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. J Transl Med 4, 37 (2006)
91. G Angelini, D Bonamonte, A Lucchese, G Favia, R Serpico, A Mittelman A, S Simone, AA Sinha, D Kanduc: Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med 4, 43 (2006)
92. D Kanduc, R Serpico, A Lucchese, Y Shoenfeld: Correlating low-similarity peptide sequences and HIV Bcell epitopes. Autoimmun Rev 7, 291-296 (2008) (Pubitemid 351284547)
93. G Lucchese, A Stufano, D Kanduc: Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol 57, 88-92 (2009)
94. A Lucchese, R Serpico, V Crincoli, Y Shoenfeld, D Kanduc: Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes. Int J Immunopathol Pharmacol 22, 639-646 (2009)
95. G Lucchese, A Stufano, M Calabro', D Kanduc: Charting the peptide crossreactome between HIV-1 and the human proteome. Front Biosci 3, 1385-1400 (2011)
96. G Lucchese, A Stufano, D Kanduc: Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself 2, 49-54 (2011)
97. D Kanduc: "Self-nonself" peptides in the design of vaccines. Curr Pharm Des 15, 3283-3289 (2009)